Literature DB >> 16061739

Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study.

Cecil M Burchfiel1, Thomas N Skelton, Michael E Andrew, Robert J Garrison, Donna K Arnett, Daniel W Jones, Herman A Taylor.   

Abstract

BACKGROUND: The metabolic syndrome has been associated with cardiovascular disease, but few studies have examined its relationship with subclinical measures such as echocardiographic left ventricular (LV) mass. This relationship is likely to be of particular importance in blacks, in whom both the metabolic syndrome and LV hypertrophy are common. METHODS AND
RESULTS: Echocardiography, performed at 1 of 4 sites in the Atherosclerosis Risk in Communities (ARIC) Study, was used to assess LV dimensions in 1572 black women and men aged 49 to 75 years in 1993-1996. Participants were categorized by number of metabolic syndrome characteristics (hypertension, dyslipidemia [low HDL cholesterol or high triglycerides], and glucose intolerance). Age-adjusted mean LV mass indexed by height (g/m) increased in a stepwise gradient with increasing number of metabolic syndrome disorders (none, any 1, any 2, all 3) in both women and men (125.1, 143.9, 153.7, 169.3 and 130.5, 148.7, 160.8, 170.2, respectively; P<0.001, tests for trend). Associations were diminished slightly by adjustment for smoking, alcohol intake, and education; additional adjustment for waist circumference resulted in some attenuation, but associations remained statistically significant. Analyses focusing on components of LV mass revealed that posterior wall and interventricular septal thickness, but not LV chamber size, were significantly and independently associated in general with the number of metabolic syndrome disorders. Consistent with these findings, relative wall thickness was also associated with number of disorders. Associations were similar across age and central adiposity. Hypertension had a strong influence on LV mass with additional contributions from dyslipidemia and glucose intolerance; strong synergistic effects of the syndrome beyond its individual components were not observed.
CONCLUSIONS: In this cross-sectional population-based study of black women and men, the degree of metabolic syndrome clustering was strongly related to LV mass and its wall thickness components. These associations are consistent with a possible influence of underlying factors such as insulin resistance or other vascular processes on myocardial thickening and not on chamber size.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061739     DOI: 10.1161/CIRCULATIONAHA.104.518498

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.

Authors:  Khiet Hoang; Yanglu Zhao; Julius M Gardin; Mercedes Carnethon; Ken Mukamal; David Yanez; Nathan D Wong
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-26

2.  Strain/strain rate imaging of impaired left atrial function in patients with metabolic syndrome.

Authors:  Ning-Ning Fang; Dong-Xin Sui; Jin-Gui Yu; Hui-Ping Gong; Ming Zhong; Yun Zhang; Wei Zhang
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

Review 3.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

4.  Racial differences in the association between heart rate variability and left ventricular mass.

Authors:  LaBarron K Hill; Lana L Watkins; Alan L Hinderliter; James A Blumenthal; Andrew Sherwood
Journal:  Exp Physiol       Date:  2017-05-26       Impact factor: 2.969

5.  Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Longjian Liu; Jennifer A Nettleton; Alain G Bertoni; David A Bluemke; João A Lima; Moyses Szklo
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

6.  Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.

Authors:  G de Simone; R B Devereux; M Chinali; M J Roman; E T Lee; H E Resnick; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-07-31       Impact factor: 4.222

7.  Abnormal cardiac structure and function in the metabolic syndrome: a population-based study.

Authors:  Bilal Aijaz; Khawaja A Ammar; Francisco Lopez-Jimenez; Margaret M Redfield; Steven J Jacobsen; Richard J Rodeheffer
Journal:  Mayo Clin Proc       Date:  2008-12       Impact factor: 7.616

8.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

9.  Preclinical left ventricular diastolic dysfunction in metabolic syndrome.

Authors:  Nir Ayalon; Deepa M Gopal; Deirdre M Mooney; Juliana S Simonetti; Jason R Grossman; Aeshita Dwivedi; Courtney Donohue; Alejandro J Perez; Jill Downing; Noyan Gokce; Edward J Miller; Chang-Seng Liang; Caroline M Apovian; Wilson S Colucci; Jennifer E Ho
Journal:  Am J Cardiol       Date:  2014-07-01       Impact factor: 2.778

10.  Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects.

Authors:  M Rigato; F Boscari; G Marcuzzo; S Vigili de Kreutzenberg; M C Marescotti; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.